%20(002).png)
Organon (Thailand) Ltd
Categories
Pharmaceutical
About Us
Our story
We believe in a better and healthier every day for every woman. And we understand that women are foundational to a healthier world.
Organon, here for her health
Organon is a global healthcare company formed through a spinoff from Merck (known as MSD outside of the U.S. and Canada) with a mission to deliver impactful medicines and solutions for a healthier every day. We build upon our strong foundation of more than 60 medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies and asthma.
We bring these important therapies around the world, with an international footprint that serves people in more than 140 markets. We believe the diversity of our business provides a sustainable engine of growth so we can continue to invest in and advance new medicines and treatments for women that are so urgently needed.
We are here for her health.
Our vision
We envision a better and healthier every day for every woman.
Our values
Our employees take the promise of Organon and turn it into a reality, with a calling to help create what has been missing in the world. Above all, we act with integrity because we are the foundation for what the company will become and our values are how we get things done around here.
Video Media
Images

Gallery Image 01_220223-023431.jpg


Gallery Image 02%20AMCHAM%20CSR%20Reg_220223-023438.jpg


Gallery Image 03.Mural1_220223-023448.jpeg


Gallery Image 04_220223-023456.jpg


Gallery Image 05.Her%20Voice_220223-023506.jpg


Gallery Image 05_220223-023515.jpg


Gallery Image 10_220223-023525.jpg


Gallery Image 11_220223-023532.jpg


Gallery Image 13_220223-023543.jpg


Gallery Image CCT_220223-023602.png


Gallery Image Picture1_220223-023636.jpg


Gallery Image Picture2_220223-023643.jpg

Rep/Contact Info

Christopher Costigan
Christopher Costigan
Executive Director

Saraporn Intaraprom
Saraporn Intaraprom
Legal lead

Piyaporn Jitbanjongkij
Piyaporn Jitbanjongkij
SCM lead

Channarong Ketsamathi
Channarong Ketsamathi
Medical Director

Mr. Koen C. Kruijtbosch
In 2008 Organon was acquired by Schering-Plough, which in 2009 was acquired by MSD, when Koen was appointed Managing Director of MSD Egypt.
In 2011 he was named Executive Director of MSD’s Institutional Business (IBA), focused on improving access to Family Planning and Vaccines in Africa.
From 2015 until 2021, Koen was MD of MSD Vietnam and was appointed Managing Director of Organon Thailand on March 1st, 2021. Organon is a NYSE-listed (OGN), biopharmaceutical company, focused on Women’s Health that spun-off from MSD on June 2nd, 2021.
Koen holds a Master of Science degree in Business Economics and Management Information Systems from the State University of Groningen in the Netherlands.
Mr. Koen C. Kruijtbosch
Managing Director

Sittipong Liamsuwan
Sittipong Liamsuwan
Access Policy and Communication Director

Panyawat Na Pattalung
Panyawat Na Pattalung
Commercial Operation lead

Tanissa Pimsamarn
Tanissa Pimsamarn
Human Resources lead

Nantanee Ratchtawongpipat
Nantanee Ratchtawongpipat
Communication Lead
